Now Accepting Public Comments on the Draft 2026 CMS QRDA I Implementation Guide (IG) for Hospital Reporting
Measure Results |
---|
CMS125v11 - Breast Cancer Screening (2023) |
CMS128v12 - Anti-depressant Medication Management (2024) |
CMS122v13 - Diabetes: Glycemic Status Assessment Greater Than 9% (2025) |
CMS646v3 - Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer (2023) |
CMS771v6 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia (2025) |
CMS127v11 - Pneumococcal Vaccination Status for Older Adults (2023) |
CMS129v13 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients (2024) |
CMS124v13 - Cervical Cancer Screening (2025) |
CMS771v4 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia (2023) |
CMS951v3 - Kidney Health Evaluation (2025) |
New to eCQMs? Learn the basics about eCQMs, development, certification, and resources to get started.
Educational resources available for eCQMs and eCQI, Tools, CQL, FHIR, QDM, and QRDA.
Key standards for the electronic transmission of health information used to support eCQMs.
Fast Healthcare Interoperability Resources® is a standard for exchanging healthcare information electronically.
The CMS Measures Under Consideration Entry/Review Information Tool (CMS MERIT) is now open for 2025 quality and efficiency measure submissions!
Section 3014 of the Patient Protection and Affordable Care Act established the CMS pre-rulemaking process for the selection of measures for…
Posted on